These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7534937)

  • 1. An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum.
    Lalvani A; Aidoo M; Allsopp CE; Plebanski M; Whittle HC; Hill AV
    Res Immunol; 1994; 145(6):461-8. PubMed ID: 7534937
    [No Abstract]   [Full Text] [Related]  

  • 2. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.
    Aidoo M; Lalvani A; Gilbert SC; Hu JT; Daubersies P; Hurt N; Whittle HC; Druihle P; Hill AV
    Infect Immun; 2000 Jan; 68(1):227-32. PubMed ID: 10603392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania.
    Lalvani A; Hurt N; Aidoo M; Kibatala P; Tanner M; Hill AV
    Eur J Immunol; 1996 Apr; 26(4):773-9. PubMed ID: 8625967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria.
    Aidoo M; Lalvani A; Allsopp CE; Plebanski M; Meisner SJ; Krausa P; Browning M; Morris-Jones S; Gotch F; Fidock DA
    Lancet; 1995 Apr; 345(8956):1003-7. PubMed ID: 7536870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing peptide-based vaccine candidates for Plasmodium falciparum erythrocyte binding antigen 175.
    Chauhan S; Kumar R; Khan N; Verma S; Sehgal R; Tripathi PK; Farooq U
    Biologicals; 2020 Sep; 67():42-48. PubMed ID: 32718776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    Sedegah M; Peters B; Hollingdale MR; Ganeshan HD; Huang J; Farooq F; Belmonte MN; Belmonte AD; Limbach KJ; Diggs C; Soisson L; Chuang I; Villasante ED
    PLoS One; 2016; 11(10):e0163026. PubMed ID: 27695088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the association of HLA-B53 and resistance to severe malaria.
    Hill AV; Elvin J; Willis AC; Aidoo M; Allsopp CE; Gotch FM; Gao XM; Takiguchi M; Greenwood BM; Townsend AR
    Nature; 1992 Dec; 360(6403):434-9. PubMed ID: 1280333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First DNA malaria vaccine on trial in Africa.
    Ferry G
    Curr Biol; 2000 Nov; 10(22):R810-1. PubMed ID: 11102816
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.
    Wang R; Doolan DL; Charoenvit Y; Hedstrom RC; Gardner MJ; Hobart P; Tine J; Sedegah M; Fallarme V; Sacci JB; Kaur M; Klinman DM; Hoffman SL; Weiss WR
    Infect Immun; 1998 Sep; 66(9):4193-202. PubMed ID: 9712767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum CS protein--prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation.
    Doolan DL; Good MF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():241-7. PubMed ID: 1285314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Review of Human
    Heide J; Vaughan KC; Sette A; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2019; 10():397. PubMed ID: 30949162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria vaccines: multiple targets.
    Nussenzweig RS; Long CA
    Science; 1994 Sep; 265(5177):1381-3. PubMed ID: 8073276
    [No Abstract]   [Full Text] [Related]  

  • 14. Malaria vaccine based on self-assembling protein nanoparticles.
    Burkhard P; Lanar DE
    Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa.
    Plebanski M; Aidoo M; Whittle HC; Hill AV
    J Immunol; 1997 Mar; 158(6):2849-55. PubMed ID: 9058821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].
    Chirkov VP; Popov AF
    Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines against the blood stages of falciparum malaria.
    Miller LH; Good MF; Kaslow DC
    Adv Exp Med Biol; 1998; 452():193-205. PubMed ID: 9889974
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview: immunology of malaria and progress in malaria vaccine development.
    Tharavanij S
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
    Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
    J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria-specific memory T cells: putative roles of different types of memory responses in immunity and disease.
    Good MF; Zevering Y
    Res Immunol; 1994; 145(6):455-60. PubMed ID: 7534936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.